```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the Infant Phototherapy Instrument market with a 38% share, driven by advanced healthcare infrastructure, high adoption of innovative technologies, and robust reimbursement policies. The region’s mature ecosystem supports rapid integration of phototherapy devices in neonatal intensive care units (NICUs)."
},
{
"type": "paragraph",
"content": "Europe holds 28% of the market, fueled by stringent regulatory frameworks ensuring device safety, strong R&D investments, and rising awareness of neonatal jaundice management. Germany and France lead adoption due to well-established healthcare systems and favorable reimbursement structures."
},
{
"type": "paragraph",
"content": The Asia Pacific region is the fastest-growing market (CAGR of 7.2%), propelled by expanding healthcare access, growing middle-class demographics, and government initiatives to improve neonatal care. Countries like India and China are scaling infrastructure, driving demand for cost-effective phototherapy solutions."
},
{
"type": "paragraph",
"content": "Latin America contributes 8% of global revenue, with growth attributed to improving healthcare facilities, rising private-sector investments, and partnerships with global device manufacturers. Brazil and Mexico are key hubs due to increasing neonatal care accessibility."
},
{
"type": "paragraph",
"content": "Middle East & Africa (4% share) exhibit steady growth, driven by rising healthcare expenditure, urbanization, and a growing focus on reducing neonatal mortality. Saudi Arabia and South Africa are pivotal in adopting phototherapy instruments to address regional jaundice prevalence."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 38 },
{ "name": "Europe", "value": 28 },
{ "name": "Asia Pacific", "value": 22 },
{ "name": "Latin America", "value": 8 },
{ "name": "Middle East & Africa", "value": 4 }
]
}
}
```
